Signaling pathways activation profiles make better markers of cancer than expression of individual genes.
about
MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.Aging Chart: a community resource for rapid exploratory pathway analysis of age-related processesTowards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression dataROMA: Representation and Quantification of Module Activity from Target Expression Data.Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus.Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cellsAltered radiation responses of breast cancer cells resistant to hormonal therapyAltered pathways and colorectal cancer prognosisFrequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityAn analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugsA method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activationPathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in humanLarge-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cellsIn search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma.Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection.In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia.Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cellsCommon pathway signature in lung and liver fibrosis.Biomarkers in hepatocellular carcinoma: an overview.Screening and personalizing nootropic drugs and cognitive modulator regimens in silicoPathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.Towards natural mimetics of metformin and rapamycin.Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells.Individual Drug Treatment Prediction in Oncology Based on Machine Learning Using Cell Culture Gene Expression Data
P2860
Q27311360-538FF2C0-21B0-4D62-850C-D20B016195D4Q28603043-C987A82D-7EAB-432A-BB13-3E5DAEBCA7DFQ31031642-7318487D-D507-4ED4-9AA0-8303E6F5D9C5Q31049998-546E03DB-E1FF-442B-9AEE-11D9A386FB48Q34619203-BAC35DBA-2031-40EE-98E8-32D1D757A0D3Q35063752-3E92C7C1-D5B0-465A-AE14-7EA0D89A0ACAQ35149536-A65BA5E0-3523-4988-ADED-8116BBFD4A62Q35176411-0989196F-EDDA-45C5-91F7-B65BB45FFC3FQ35313181-AD05EEBD-F0E1-48B8-A70A-90E42FD2C525Q35907666-0518033C-33D9-45C8-A363-061C89F6EC3BQ36370196-CD0EFE10-0ABE-453A-B67B-C5C20D1725CAQ36382520-80CF624A-B1A3-43B8-9B73-DE900DE1EBD8Q36395686-7F6962BA-F0AF-4C70-9CBB-25C22AF44408Q36413738-3C42ED43-E8B6-4859-92BE-FDB464D20C52Q36557305-3FF5AD88-8F72-44E1-BEAD-49CB1A6F0DCEQ36671291-A8A2FF40-AA7E-4577-BA68-D919319DEB83Q36729496-B40DC20D-A498-46B9-B643-8830A6CA7CA3Q37289808-89E18473-6F21-4382-80F7-636F111030EEQ37361055-38560DFC-6294-47ED-9A53-BD49F79575CBQ38446855-65DAF7D1-BE10-456E-B88D-026D9A0EB7EAQ38604283-91D8A04E-510E-4B47-B39D-ED324ECC7577Q38604285-53BD49D6-69B8-4721-85E7-6508AA363115Q38616209-46FC93D9-82A1-45AA-8F7E-4BA7B1DBBBFCQ38665685-39A1AD1C-7CF0-4C1F-AB02-3C6368193A92Q38674897-1F68F6CD-C40D-4212-BD29-BF1807646587Q38839000-66FEF9E4-1F99-43B2-AEF9-AB6AF9D2F689Q38857496-315CF6D2-0134-4CCC-92FE-1801E01F0CE0Q39202758-FDC1EAA7-E2B4-485B-B133-A3CD90674FEFQ41370019-1734944F-3BF2-4FB6-AFA0-8FA27334463DQ41807717-04F40C7D-C038-4D4D-9A2D-14C1EDC18244Q44644664-FCB60DFB-0865-477C-AF51-9D48414479FDQ47140599-112CA64B-1541-4CCE-9A7A-3B80238F7307Q50319620-3928C8FA-F2B0-4585-A0E9-9F808B410428Q59209797-B0F1A45D-485D-4D0B-BB4A-46F186E31F49
P2860
Signaling pathways activation profiles make better markers of cancer than expression of individual genes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Signaling pathways activation ...... xpression of individual genes.
@en
type
label
Signaling pathways activation ...... xpression of individual genes.
@en
prefLabel
Signaling pathways activation ...... xpression of individual genes.
@en
P2093
P2860
P356
P1433
P1476
Signaling pathways activation ...... expression of individual genes
@en
P2093
Alex A Zhavoronkov
Alexander M Aliper
Anton A Buzdin
Larisa S Venkova
Mikhail B Korzinkin
Nadezhda V Terekhanova
Nikolay M Borisov
Philip Yu Smirnov
P2860
P304
10198-10205
P356
10.18632/ONCOTARGET.2548
P407
P577
2014-10-01T00:00:00Z